Incidence of antibodies in cerebrospinal fluid of patients with multiple sclerosis treated with interferon beta.
Andres M
AM
Villa
Cristina
C
Videla
Orlando
O
Garcea
Guadalupe
G
Carballal
D057134:Antibodies, Neutralizing / Q000134:cerebrospinal fluid*; D001666:Binding Sites, Antibody; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D015994:Incidence; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000188:drug therapy*
D057134:Antibodies, Neutralizing; D007155:Immunologic Factors; D016899:Interferon-beta